Comparison of Two Different Treatment Methods

Musculoskeletal Pain Clinical Trial

Official title:

Comparison of Short-term Effects of Two Different Treatment Methods in Patients With Subacromial Impingement Syndrome: a Randomized Controlled Single-blind Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05071469
• Other study ID #: 180030/16
• Status: Completed
• Phase: N/A
• Start date: September 28, 2021
• Est. completion date: November 30, 2021

Study information

• Verified date: December 2022
• Source: Mugla Sitki Koçman University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).

Description:

Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: November 30, 2021
• Est. primary completion date: October 15, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 35 Years to 65 Years

Eligibility

Inclusion Criteria:

• Impingement symptoms in clinical tests

• Pain >1 month

Exclusion Criteria:

• Any shoulder pathology.

• Have chronic systemic diseases or infections.

• History of any surgery shoulder complex.

• steroid injections and therapeutic approaches

Related Conditions & MeSH terms

• Muscle Weakness
• Musculoskeletal Diseases
• Musculoskeletal Injury
• Musculoskeletal Pain
• Rotator Cuff Injuries
• Shoulder Impingement Syndrome
• Subacromial Impingement Syndrome
• Syndrome
• Weakness, Muscle

Intervention

Other:
• Kinesiotaping
KT was applied.
• Mulligan Mobilization Technique
MMT was applied

Locations

Country	Name	City	State
Turkey	Mugla Sitki Koçman University	Mugla

Sponsors (2)

Lead Sponsor	Collaborator
Banu BAYAR	Mugla Sitki Koçman University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change of pain severity	Via VAS.	Baseline- after 2 weeks (after treatment)
Primary	Change of Range of Motion	Via goniometer.	Baseline- after 2 weeks (after treatment)
Primary	Change of Functionality	Via SPADI.	Baseline- after 2 weeks (after treatment)
Secondary	Change of Sleep Quality	Via VAS.	Baseline- after 2 weeks (after treatment)
Secondary	Change of Satisfaction of Life	Via SWLS.	Baseline- after 2 weeks (after treatment)
Secondary	Change of Satisfaction of Treatment	Via VAs.	Baseline- after 2 weeks (after treatment)